Pahl Pharmaceutical Research, Inc. — Oklahoma City, Oklahoma

Pahl Pharmaceutical Research, Inc. is a clinical research site located in Oklahoma City, Oklahoma, United States 73118.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Pahl Pharmaceutical Research, Inc. has participated in 1 clinical trials.

Therapeutic areas: Attention Deficit Hyperactivity Disorder.

Sponsors: Cephalon.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pahl Pharmaceutical Research, Inc.?

Pahl Pharmaceutical Research, Inc. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pahl Pharmaceutical Research, Inc. conducted?

Pahl Pharmaceutical Research, Inc. has 1 clinical trials on record. Their work covers Attention Deficit Hyperactivity Disorder.

Is Pahl Pharmaceutical Research, Inc. accredited by Crixeo Health?

Pahl Pharmaceutical Research, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pahl Pharmaceutical Research, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.